Organisms | Evidence |
---|---|
Mus musculus (house mouse) | |
Rattus norvegicus (Norway rat) | |
Homo sapiens (human) | |
Drosophila melanogaster (fruit fly) | |
Streptococcus pneumoniae |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT1 | UDP-Gal |
|
R |
|
R | |
B3GALT5 | UDP-Gal |
|
R |
|
R |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
A2A7S8 | NHS-like protein 3 | ||
A2A863 | Integrin beta-4 | ||
A2A884 | Transcription factor HIVEP3 | ||
A2A8L5 | Receptor-type tyrosine-protein phosphatase F | ||
A2A8N0 | PRAME like 26 | ||
A2ABU4 | Myomesin-3 | ||
A2AG50 | MAP7 domain-containing protein 2 | ||
A2AGT5 | Cytoskeleton-associated protein 5 | ||
A2AH22 | Activating molecule in BECN1-regulated autophagy protein 1 | ||
A2AHC3 | Calmodulin-regulated spectrin-associated protein 1 |
Pathway Name | Organism |
---|---|
Lectin pathway of complement activation | Rattus norvegicus |
Lectin pathway of complement activation | Homo sapiens |
Lectin pathway of complement activation | Canis familiaris |
Lectin pathway of complement activation | Sus scrofa |
Lectin pathway of complement activation | Bos taurus |
Lectin pathway of complement activation | Mus musculus |
Lectin pathway of complement activation | Gallus gallus |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
34135340 | Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers | Rujas E | 2021 Jun 16 |
|
34135507 | Structural basis of omega-3 fatty acid transport across the blood–brain barrier | Cater RJ | 2021 Jun 16 |
|
34142147 | Evidence for nutrient-dependent regulation of the COPII coat by O-GlcNAcylation | Bisnett BJ | 2021 Jun 15 |
|
34211469 | Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses | Bullen G | 2021 Jun 15 |
|
33811992 | Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO) | Hu CH | 2021 Jun 15 |
|
34051053 | Balancing O‐GlcNAc and O‐fucose in plants | Mutanwad KV | 2021 Jun 11 |
|
34015271 | B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV | Scheid JF | 2021 Jun 10 |
|
33974910 | Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia | Asarnow D | 2021 Jun 10 |
|
34105348 | O-GlcNAcylation Quantification of Certain Protein by the Proximity Ligation Assay and Clostridium perfringen OGA(D298N)(CpOGA(D298N)) | Song J | 2021 Jun 09 |
|
34018203 | Molecular basis of cross‐species ACE2 interactions with SARS‐CoV‐2‐like viruses of pangolin origin | Niu S | 2021 Jun 08 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025